ArticleMetabolism: clinical and experimental2020

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.

Maria Dalamaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.